Key Nutrients and Mental Health

Sponsor
University of Bergen (Other)
Overall Status
Completed
CT.gov ID
NCT03336125
Collaborator
Wisconsin Department of Health and Family Services (Other), Haukeland University Hospital (Other), National Institute of Nutrition and Seafood Research, Norway (Other)
86
1
2
6.1
14.1

Study Details

Study Description

Brief Summary

The purpose of the project is to investigate whether an intervention program with vitamin D supplementation is able to improve the biology of stress resilience as well as subjective well-being in individuals with antisocial behavior problems (forensic inpatients).

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Vitamin D
  • Dietary Supplement: Placebo
N/A

Detailed Description

This is a randomized control trial looking at the effects of vitamin D supplements on mental health in a group of forensic inpatients. More specific the effects of vitamin D will be investigated in relation to underlying biological mechanisms associated with resilience (e.g., serotonin, cortisol, heart rate variability and executive functioning), but also subjective well-being such as sleep quality, anxiety, depression, self-reported resilience and physical activity. About 100 participants will be randomized to an intervention group (vitamin D) or a control group (placebo). The intervention will last for 3-4 months. Pre-test will start in October/November 2017 and post-test in April/May 2018.

Study Design

Study Type:
Interventional
Actual Enrollment :
86 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Pre and post-test designPre and post-test design
Masking:
Single (Participant)
Masking Description:
Double blind
Primary Purpose:
Supportive Care
Official Title:
Key Nutrients and Mental Health
Actual Study Start Date :
Nov 17, 2017
Actual Primary Completion Date :
May 22, 2018
Actual Study Completion Date :
May 22, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Vitamin D group

Intervention is vitamin D supplement

Dietary Supplement: Vitamin D
Vitamin D (40µg/day) will be compared with placebo

Placebo Comparator: Control group

Placebo capsule contains olive oil

Dietary Supplement: Placebo
120 mg olive oil

Outcome Measures

Primary Outcome Measures

  1. Change in vitamin D level in blood from pre-test (baseline) to post-test (after 4 months) [Time for blood sample: about 10-15 minutes (at both pre and post test)]

    Measured from blood sample

  2. Change in serotonin from pre-test (baseline) to post-test (after 4 months) [Time for blood sample: about 10-15 minutes (at both pre and post test)]

    Measured form blood sample

  3. Change in total cholesterol from pre-test (baseline) to post-test (after 4 months) [Time for blood sample: about 10-15 minutes (at both pre and post test)]

    Measured from blood sample

  4. Change in lipoproteins from pre-test (baseline) to post-test (after 4 months) [Time for blood sample: about 10-15 minutes (at both pre and post test)]

    Measured from blood sample

  5. Change in triglycerides from pre-test (baseline) to post-test (after 4 months) [Time for blood sample: about 10-15 minutes (at both pre and post-test)]

    Measured from blood sample

  6. Change in cortisol from pre-test (baseline) to post-test (after 4 months) [7 samples over 24 hours (at both pre and post-test)]

    Saliva

  7. Change in performance on working memory tasks (N-back) from pre-test (baseline) to post-test (after 4 months) [About 8-10 minutes (at both pre and post-test)]

    Computerized cognitive task

  8. Change in performance on Tower of Hanoi Task from pre-test (baseline) to post-test (after 4 months) [About 10-15 minutes (at bot pre and post-test)]

    Computerized cognitive task

  9. Change in performance on Tower of London Task from pre-test (baseline) to post-test (after 4 months) [About 10-15 minutes (at both pre and post test)]

    Computerized cognitive task

  10. Change in performance on Iowa Gambling Task from pre-test (baseline) to post-test (after 4 months) [About 15-20 minutes (at both pre and post test)]

    Computerized cognitive task

  11. Change in heart rate variability from pre-test (baseline) to post-test (after 4 months) [5 minutes of baseline, during the cognitive testing (up to 60 minutes) and 5 minutes of recovery (at both pre and post test)]

Secondary Outcome Measures

  1. Change in sleep from pre-test (baseline) to post-test (after 4 months) [One week before intervention and one week after intervention (i.e., pre and post-test)]

    Measured by Ambulatory Monitoring System together with a sleep log

  2. Change on Epworth Sleepiness Scale from pre-test (baseline) to post-test (after 4 months) [About 5-10 minutes (at both pre and post-test)]

  3. Houston Non-Exercise Questionnaire [The physical activity log will be filled out weekly over the course of the study period (i.e., 24 -28 weeks) and estimated time per week is 10 minutes.]

    The log consists of weekly recording of various activity levels.

  4. Change in self-reported state and trait anxiety (STAI questionnaire) from pre-test (baseline) to post-test (after 4 months) [About 10 minutes (at both pre and post-test)]

  5. Change in self-reported resilience (Connor-Davidson Resilience Scale 25) from pre-test (baseline) to post-test (after 4 months) [About 5 minutes (at both pre and post-test)]

  6. Change in post-traumatic stress symptoms (Impact of event scale -Revised) from pre-test (baseline) to post-test (after 4 months) [About 5-10 minutes (at both pre and post-test)]

  7. Change in self-reported depression (Beck Depression Inventory) from pre-test (baseline) to post-test (after 4 months) [About 5-10 minutes (at both pre and post-test)]

Other Outcome Measures

  1. Childhood Trauma Questionnaire [About 10 minutes (only at pre-test)]

  2. Iodine (test 1) [About 2-3 minutes]

    Urin

  3. Iodine (test 2) [About 2-3 minutes]

    Urin

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with intelligence quotient > 70 will be invited.
Exclusion Criteria:
  • Patients with intelligence quotient <70 will be excluded.

  • Patients already taking vitamin D.

  • Patients with psychotic disorders.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sand Ridge Secure Treatment Center Mauston Wisconsin United States 53948

Sponsors and Collaborators

  • University of Bergen
  • Wisconsin Department of Health and Family Services
  • Haukeland University Hospital
  • National Institute of Nutrition and Seafood Research, Norway

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anita Lill Hansen, Professor, University of Bergen
ClinicalTrials.gov Identifier:
NCT03336125
Other Study ID Numbers:
  • 983 974 724
First Posted:
Nov 8, 2017
Last Update Posted:
Jun 28, 2019
Last Verified:
Jun 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 28, 2019